| Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS (NCT01133275) | H. Lee Moffitt Cancer Center and Research Institute | 2010-04-28 |
| Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD) (NCT01111526) | H. Lee Moffitt Cancer Center and Research Institute | 2010-04-01 |
| Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) (NCT01090973) | H. Lee Moffitt Cancer Center and Research Institute | 2010-03-01 |
| Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma (NCT01054144) | H. Lee Moffitt Cancer Center and Research Institute | 2010-01-14 |
| Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer (NCT01419210) | H. Lee Moffitt Cancer Center and Research Institute | 2010-01-01 |
| Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas (NCT01048723) | H. Lee Moffitt Cancer Center and Research Institute | 2010-01-01 |
| Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer (NCT01042535) | H. Lee Moffitt Cancer Center and Research Institute | 2009-12-28 |
| Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, Effectiveness (NCT01036321) | H. Lee Moffitt Cancer Center and Research Institute | 2009-12-11 |
| Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma (NCT01005745) | H. Lee Moffitt Cancer Center and Research Institute | 2009-10-20 |
| Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100 (NCT01008527) | H. Lee Moffitt Cancer Center and Research Institute | 2009-10-01 |
| Erlotinib Study for Myelodysplastic Syndrome (MDS) (NCT00977548) | H. Lee Moffitt Cancer Center and Research Institute | 2009-09-01 |
| Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia (NCT00985777) | H. Lee Moffitt Cancer Center and Research Institute | 2009-09-01 |
| Depocyt® With Sorafenib in Neoplastic Meningitis (NCT00964743) | H. Lee Moffitt Cancer Center and Research Institute | 2009-08-01 |
| CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML) (NCT00955916) | H. Lee Moffitt Cancer Center and Research Institute | 2009-08-01 |
| Facts and Attitudes About Clinical Trials (NCT01269645) | H. Lee Moffitt Cancer Center and Research Institute | 2009-07-01 |
| Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) (NCT00831766) | H. Lee Moffitt Cancer Center and Research Institute | 2009-06-25 |
| Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma (NCT00948922) | H. Lee Moffitt Cancer Center and Research Institute | 2009-06-18 |
| Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors (NCT00879073) | H. Lee Moffitt Cancer Center and Research Institute | 2009-04-01 |
| Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery (NCT00833859) | H. Lee Moffitt Cancer Center and Research Institute | 2009-03-01 |
| Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation (NCT00858403) | H. Lee Moffitt Cancer Center and Research Institute | 2009-03-01 |
| Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS) (NCT00840931) | H. Lee Moffitt Cancer Center and Research Institute | 2009-02-02 |
| Extended Self-Help for Smoking Cessation (NCT01352195) | H. Lee Moffitt Cancer Center and Research Institute | 2009-01-23 |
| Liposuction for Arm Lymphedema Following Breast Cancer Surgery (NCT00816985) | H. Lee Moffitt Cancer Center and Research Institute | 2008-12-03 |
| PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment (NCT00694551) | H. Lee Moffitt Cancer Center and Research Institute | 2008-12-02 |
| Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline("Quitline") (NCT01352000) | H. Lee Moffitt Cancer Center and Research Institute | 2008-12-01 |
| Pilot Study of a Geriatric Intervention After Colorectal and Lung Cancer Surgery (NCT01416168) | H. Lee Moffitt Cancer Center and Research Institute | 2008-12-01 |
| Managing Medication-induced Constipation in Cancer: A Clinical Trial (NCT01416909) | H. Lee Moffitt Cancer Center and Research Institute | 2008-11-01 |
| Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers (NCT00738751) | H. Lee Moffitt Cancer Center and Research Institute | 2008-11-01 |
| Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured (NCT00798629) | H. Lee Moffitt Cancer Center and Research Institute | 2008-11-01 |
| Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM) (NCT00750815) | H. Lee Moffitt Cancer Center and Research Institute | 2008-09-01 |
| Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation (NCT00803010) | H. Lee Moffitt Cancer Center and Research Institute | 2008-09-01 |
| Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement (NCT00747643) | H. Lee Moffitt Cancer Center and Research Institute | 2008-09-01 |
| A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma (NCT00762255) | H. Lee Moffitt Cancer Center and Research Institute | 2008-09-01 |
| Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection (NCT00751140) | H. Lee Moffitt Cancer Center and Research Institute | 2008-09-01 |
| Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients (NCT00815750) | H. Lee Moffitt Cancer Center and Research Institute | 2008-08-01 |
| Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or Topotecan (NCT00720096) | H. Lee Moffitt Cancer Center and Research Institute | 2008-07-01 |
| Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms (NCT00665002) | H. Lee Moffitt Cancer Center and Research Institute | 2008-06-01 |
| Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC) (NCT00673738) | H. Lee Moffitt Cancer Center and Research Institute | 2008-04-01 |
| Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant (NCT00660400) | H. Lee Moffitt Cancer Center and Research Institute | 2008-03-01 |
| Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Tx (NCT00802932) | H. Lee Moffitt Cancer Center and Research Institute | 2008-03-01 |
| Study of Oral Dasatinib in Subjects With Myelodysplastic Syndrome (MDS) and Excess Marrow Blasts (NCT00624585) | H. Lee Moffitt Cancer Center and Research Institute | 2008-02-01 |
| Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM) (NCT00617591) | H. Lee Moffitt Cancer Center and Research Institute | 2008-01-01 |
| Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation (NCT00720629) | H. Lee Moffitt Cancer Center and Research Institute | 2007-12-01 |
| Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia (NCT00596011) | H. Lee Moffitt Cancer Center and Research Institute | 2007-11-14 |
| A Phase I/II Study of Dasatinib and Dacarbazine (NCT00597038) | H. Lee Moffitt Cancer Center and Research Institute | 2007-11-01 |
| To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid (NCT00617409) | H. Lee Moffitt Cancer Center and Research Institute | 2007-10-02 |
| Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM) (NCT00604461) | H. Lee Moffitt Cancer Center and Research Institute | 2007-10-01 |
| Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Rituximab (NCT00609869) | H. Lee Moffitt Cancer Center and Research Institute | 2007-10-01 |
| Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer (NCT01662609) | H. Lee Moffitt Cancer Center and Research Institute | 2007-08-23 |
| Effects of Yoga and Cardiovascular Exercise on Smoking Motivation (NCT01423578) | H. Lee Moffitt Cancer Center and Research Institute | 2007-08-21 |
| Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors (NCT00609765) | H. Lee Moffitt Cancer Center and Research Institute | 2007-08-01 |
| Phase II Trial of Pentostatin and Targeted Busulfan (NCT00496340) | H. Lee Moffitt Cancer Center and Research Institute | 2007-07-01 |
| A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia (NCT00815685) | H. Lee Moffitt Cancer Center and Research Institute | 2007-07-01 |
| Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem (NCT00612677) | H. Lee Moffitt Cancer Center and Research Institute | 2007-06-01 |
| Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma (NCT00598507) | H. Lee Moffitt Cancer Center and Research Institute | 2007-05-01 |
| Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer (NCT00776295) | H. Lee Moffitt Cancer Center and Research Institute | 2007-05-01 |
| Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC (NCT00499109) | H. Lee Moffitt Cancer Center and Research Institute | 2007-05-01 |
| Patient Navigator Project (NCT00375024) | H. Lee Moffitt Cancer Center and Research Institute | 2007-05-01 |
| A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer (NCT00480584) | H. Lee Moffitt Cancer Center and Research Institute | 2007-04-01 |
| A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma (NCT00606008) | H. Lee Moffitt Cancer Center and Research Institute | 2007-03-01 |
| Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC) (NCT00444015) | H. Lee Moffitt Cancer Center and Research Institute | 2007-03-01 |
| Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma (NCT00504257) | H. Lee Moffitt Cancer Center and Research Institute | 2007-03-01 |
| Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases (NCT00437957) | H. Lee Moffitt Cancer Center and Research Institute | 2006-12-01 |
| Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization (NCT00434109) | H. Lee Moffitt Cancer Center and Research Institute | 2006-11-01 |
| Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma (NCT00400569) | H. Lee Moffitt Cancer Center and Research Institute | 2006-11-01 |
| Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC) (NCT00495625) | H. Lee Moffitt Cancer Center and Research Institute | 2006-10-01 |
| The Human Papillomavirus (HPV) Transmission Pilot Study (NCT00823511) | H. Lee Moffitt Cancer Center and Research Institute | 2006-10-01 |
| Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer (NCT00601796) | H. Lee Moffitt Cancer Center and Research Institute | 2006-10-01 |
| A Phase I/II Study of Sunitinib and Dacarbazine (NCT00496223) | H. Lee Moffitt Cancer Center and Research Institute | 2006-09-01 |
| Support for People Undergoing Chemotherapy (NCT00740038) | H. Lee Moffitt Cancer Center and Research Institute | 2006-08-01 |
| Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) in CR After Induction Chemotherapy (NCT00387647) | H. Lee Moffitt Cancer Center and Research Institute | 2006-08-01 |
| Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma (NCT00365222) | H. Lee Moffitt Cancer Center and Research Institute | 2006-07-01 |
| Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer (NCT00351039) | H. Lee Moffitt Cancer Center and Research Institute | 2006-07-01 |
| Drug /Cue Interactions In Alcohol-Tobacco Comorbidity (NCT00816231) | H. Lee Moffitt Cancer Center and Research Institute | 2006-05-08 |
| External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma (NCT00365872) | H. Lee Moffitt Cancer Center and Research Institute | 2006-05-01 |
| Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation (NCT00363467) | H. Lee Moffitt Cancer Center and Research Institute | 2006-05-01 |
| Evaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk Assess (NCT00822822) | H. Lee Moffitt Cancer Center and Research Institute | 2006-03-01 |
| Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas (NCT00360828) | H. Lee Moffitt Cancer Center and Research Institute | 2006-02-01 |
| Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer (NCT00365599) | H. Lee Moffitt Cancer Center and Research Institute | 2006-02-01 |
| Dendritic Cell Vaccination During Lymphoid Reconstruction (NCT00313508) | H. Lee Moffitt Cancer Center and Research Institute | 2006-02-01 |
| Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX (NCT00360685) | H. Lee Moffitt Cancer Center and Research Institute | 2005-09-01 |
| Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) (NCT00361140) | H. Lee Moffitt Cancer Center and Research Institute | 2005-08-01 |
| A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma (NCT00361088) | H. Lee Moffitt Cancer Center and Research Institute | 2005-08-01 |
| Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation. (NCT00216008) | H. Lee Moffitt Cancer Center and Research Institute | 2005-07-01 |
| Natural History of HPV Infection in Men: The HIM Study (NCT00786760) | H. Lee Moffitt Cancer Center and Research Institute | 2005-06-14 |
| Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants (NCT00307086) | H. Lee Moffitt Cancer Center and Research Institute | 2005-06-01 |
| Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma (NCT00358319) | H. Lee Moffitt Cancer Center and Research Institute | 2005-03-01 |
| Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer (NCT00215982) | H. Lee Moffitt Cancer Center and Research Institute | 2004-12-01 |
| Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates (NCT00104728) | H. Lee Moffitt Cancer Center and Research Institute | 2004-10-01 |
| Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma (NCT00101166) | H. Lee Moffitt Cancer Center and Research Institute | 2004-10-01 |
| Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer (NCT00100906) | H. Lee Moffitt Cancer Center and Research Institute | 2004-08-01 |
| Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma (NCT00101101) | H. Lee Moffitt Cancer Center and Research Institute | 2004-07-01 |
| Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma (NCT00323206) | H. Lee Moffitt Cancer Center and Research Institute | 2004-06-01 |
| Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies (NCT00246103) | H. Lee Moffitt Cancer Center and Research Institute | 2004-03-01 |
| The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer (NCT00215930) | H. Lee Moffitt Cancer Center and Research Institute | 2004-02-01 |
| Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer. (NCT00226577) | H. Lee Moffitt Cancer Center and Research Institute | 2004-02-01 |
| Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A) (NCT00127036) | H. Lee Moffitt Cancer Center and Research Institute | 2003-10-01 |
| Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas (NCT00215995) | H. Lee Moffitt Cancer Center and Research Institute | 2003-07-01 |
| Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer (NCT00231465) | H. Lee Moffitt Cancer Center and Research Institute | 2003-07-01 |
| Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) (NCT00215943) | H. Lee Moffitt Cancer Center and Research Institute | 2003-06-01 |